The FDA has granted fast track designation to Amylyx's experimental therapy AMX0114 for the treatment of amyotrophic lateral ...

Department of Biochemistry, Queen’s University, Kingston, Ontario, Canada K7L 3N6, and Service and Department of Medical Genetics, Centre Hospitalier Universitaire Vaudois, CHUV, and Faculty of ...